|
|
|
|
| LEADER |
02861nam a22003735i 4500 |
| 001 |
978-1-4020-9464-4 |
| 005 |
20191022072848.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2009 ne | s |||| 0|eng d |
| 020 |
|
|
|a 9781402094644
|
| 024 |
7 |
|
|a 10.1007/978-1-4020-9464-4
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
4 |
|a The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes
|b Volume I: Neuropsychological Endophenotypes and Biomarkers /
|c edited by Michael Ritsner.
|
| 250 |
|
|
|a 1st ed. 2009.
|
| 260 |
# |
# |
|a Dordrecht :
|b Springer Netherlands :
|b Imprint: Springer,
|c 2009.
|
| 300 |
|
|
|a XIV, 273 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Methodological and Technological Advances -- Where Do We Stand in the Quest for Neuropsychiatric Biomarkers and Endophenotypes and What Next? -- Methodological and Statistical Issues in the Use of Biomarkers in Clinical and Research Studies -- Challenging the Genetic Complexity of Schizophrenia by Use of Intermediate Phenotypes -- Translational Medicine: Functional Biomarkers for Drug Development of “Cognitive Enhancers” in Schizophrenia -- Leveraging High-Dimensional Neuroimaging Data in Genetic Studies of Neuropsychiatric Disease -- Proteomics as a New Tool for Biomarker-Discovery in Neuropsychiatric Disorders -- Schizophrenia Endophenotypes as Treatment Targets -- Neuropsychological, Neurocognitive and Neurophysiological Domains -- Neuropsychological Endophenotypes in Schizophrenia and Bipolar I Disorder: Yields from the Finnish Family and Twin Studies -- Is More Cognitive Experimental Psychopathology of Schizophrenia Really Necessary? Challenges and Opportunities -- Intellectual Functioning as an Endophenotype for Schizophrenia -- Emotion Recognition Deficits as a Neurocognitive Marker of Schizophrenia Liability -- The Use of Neurocognitive Endophenotypes in Large-Scale Family Genetic Studies of Schizophrenia -- Neurocognitive Endophenotypes for Bipolar Disorder: Evidence from Case-Control, Family and Twin Studies -- Trait and State Markers of Schizophrenia in Visual Processing -- Visual Scanning Abnormalities as Biomarker for Schizophrenia -- Biomarkers and Endophenotypes in Eating Disorders -- Movement Abnormalities: A Putative Biomarker of Risk for Psychosis.
|
| 650 |
|
0 |
|a Neurosciences.
|
| 650 |
|
0 |
|a Psychiatry.
|
| 650 |
|
0 |
|a Neurology .
|
| 650 |
|
0 |
|a Human genetics.
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
1 |
4 |
|a Neurosciences.
|
| 650 |
2 |
4 |
|a Psychiatry.
|
| 650 |
2 |
4 |
|a Neurology.
|
| 650 |
2 |
4 |
|a Human Genetics.
|
| 650 |
2 |
4 |
|a Biomedicine, general.
|
| 700 |
1 |
|
|a Ritsner, Michael.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-1-4020-9464-4
|